CTMX icon

CytomX Therapeutics
CTMX

Overview Fund Activity

69 hedge funds and large institutions have $60.4M invested in CytomX Therapeutics in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 13 closing their positions.

Holders
69
Holders Change
-5
Holders Change %
-6.76%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
19
Reduced
23
Closed
13
Calls
$143K
Puts
$10K
Net Calls
+$133K
Net Calls Change
+$146K

Top Buyers

1
PM
1
Prosight Management
Texas
$3.57M
2
ACM
2
Altium Capital Management
New York
$1.08M
3
Millennium Management
3
Millennium Management
New York
$3.02M
4
Assenagon Asset Management
4
Assenagon Asset Management
Luxembourg
$1.94M
5
WP
5
Woodline Partners
California
$465K

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$5.7M
2
RI
2
RTW Investments
New York
$0
3
SCM
3
Superstring Capital Management
New York
$0
4
GTC
4
Ghost Tree Capital
New York
$0
5
LCM
5
Laurion Capital Management
New York
$1.47M
Name Market Value Shares Shares
Change 		Shares
Change %
Two Sigma Advisers
76
Two Sigma Advisers
New York
– – -158,400 Closed
LP
77
LMR Partners
United Kingdom
– – -15,046 Closed
Simplex Trading
78
Simplex Trading
Illinois
– – -3,891 Closed
WT
79
Whittier Trust
California
– – -2,200 Closed
RhumbLine Advisers
80
RhumbLine Advisers
Massachusetts
– – -1,291 Closed
Royal Bank of Canada
81
Royal Bank of Canada
Ontario, Canada
– – -248 Closed
IC
82
Innealta Capital
Texas
– – -2 Closed
CFGS
83
Concourse Financial Group Securities
Alabama
– – – –
1 2 3
4